The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance.
about
Drug resistance in multiple myeloma: latest findings and new concepts on molecular mechanisms.Putting tumours in contextLeveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid TumorsThe breast cancer beta 4 integrin and endothelial human CLCA2 mediate lung metastasis.Interpreting the molecular biology and clinical behavior of multiple myeloma in the context of global gene expression profiling.A review of the proteasome inhibitor bortezomib in multiple myeloma.MYCN enhances P-gp/MDR1 gene expression in the human metastatic neuroblastoma IGR-N-91 model.Extracellular matrix in bone marrow can mediate drug resistance in myeloma.Correlation between the tumoral expression of beta3-integrin and outcome in cervical cancer patients who had undergone radiotherapyA physical sciences network characterization of non-tumorigenic and metastatic cellsReelin promotes the adhesion and drug resistance of multiple myeloma cells via integrin β1 signaling and STAT3.Liposomes targeting tumour stromal cells.Environmental-mediated drug resistance: a target for multiple myeloma therapy.Computational challenges of tumor spheroid modeling.Modulation of Tumor Cell Survival, Proliferation, and Differentiation by the Peptide Derived from Tenascin-C: Implication of β1-Integrin Activation.Implication of tumor microenvironment in chemoresistance: tumor-associated stromal cells protect tumor cells from cell death.Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review.Cell adhesion down-regulates the expression of vacuolar protein sorting 4B (VPS4B) and contributes to drug resistance in multiple myeloma cells.Evolutionary scalpels for dissecting tumor ecosystems.Cell adhesion to fibronectin down-regulates the expression of Spy1 and contributes to drug resistance in multiple myeloma cells.An individualised signature for predicting response with concordant survival benefit for lung adenocarcinoma patients receiving platinum-based chemotherapy.Integrin β7-mediated regulation of multiple myeloma cell adhesion, migration, and invasion.Apoptotic death of hematopoietic tumor cells through potentiated and sustained adhesion to fibronectin via VLA-4Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferationHSP70 inhibition reverses cell adhesion mediated and acquired drug resistance in multiple myeloma.IL-6 regulates CD44 cell surface expression on human myeloma cells.Hyaluronan, a major non-protein glycosaminoglycan component of the extracellular matrix in human bone marrow, mediates dexamethasone resistance in multiple myeloma.Circulating endothelial cells and their progenitors in acute myeloid leukemia.Stimulation of Toll-like receptor-1/2 combined with Velcade increases cytotoxicity to human multiple myeloma cells.Cancer stem cell and stromal microenvironmentThe insulin-like growth factor-I receptor inhibitor NVP-AEW541 provokes cell cycle arrest and apoptosis in multiple myeloma cells.Acute myelogenous leukemia--microenvironment interactions: role of endothelial cells and proteasome inhibition.Reduced risk of apoptosis: mechanisms of stress responses.
P2860
Q27692033-25F7CA1B-DB4F-4A45-BAA8-26DD62449646Q28207789-E3CD5176-AC8F-4DC5-AE6C-C6C4CDCEDDBAQ28553729-7BDC5F6E-FB88-43A4-BFF8-427106361EC8Q33943941-E8AAED3B-683A-4B8F-993E-B79FB4E4F253Q35170930-CFDBD230-EA13-4ACA-AB00-7E749B6F10F1Q35784057-E0B98439-9997-4791-9206-E02AB80407D9Q35791530-BC33656C-0335-40FC-8664-768E70F891C9Q36194659-F43003B3-F40E-4AC7-B7CF-BA8B28AC43BBQ36615716-3D5E015D-9594-4ADF-BFE1-FACA70EE0A73Q36795613-ADD9A11A-F59E-4C1F-8DBC-A79805F88C6AQ36962815-9F07EC24-7E50-42C8-A907-A08A66667567Q37799613-CC6966D6-B8F1-44CC-94D0-8CDA4272D744Q37810085-041947F5-F443-4101-9A06-AFE78C74AE94Q37903301-71736A1B-2978-4985-A1ED-DFB72A2378DEQ37973062-63D85272-33CF-4D46-8F4E-E10B997C356DQ38040787-0832723F-6107-489C-AB3F-2BCAC3FFC762Q38109551-46D06281-BCF6-4E36-9919-2DD9A9B5CEDBQ38895636-A961FCC2-724D-48FC-98BB-31AF7011B10FQ39030938-EBB19AF3-E85C-4875-813B-868DEEAFAAF7Q39095903-9BF74C09-88B5-4AD5-A279-B86B87083F84Q39180729-78D172DD-808C-405E-BAFB-548BAC6F2186Q39562168-11674122-BA57-45C0-83A5-20D513EBFB63Q39761913-76E00DD9-80CF-44FF-BC2C-E6CE2E1DA992Q39893169-D2FE9F9C-FCD4-48F3-9DB9-27CA064F21E9Q39978610-8E5C5C96-9471-451F-9C5F-F94098A2A73DQ40579834-47466E2A-1F66-449C-818C-6BE6FD3E5F03Q40655653-663C4417-5E42-4D97-8456-7F78520B9813Q41153604-88209C92-D406-4B1A-A91D-CEC5A7FB782AQ41876189-84876F78-572C-4618-AE26-8E91D81C8192Q42540118-CC998125-095C-4633-891F-DA778B3B3A94Q44541080-4F705642-2D05-4885-85C5-37FE9B8A78FFQ46830755-D21D26FC-5141-4BD7-BD5F-0BC68ACE7EE8Q51347935-00529B23-1079-4992-B43F-220498EC83E1
P2860
The tumor microenvironment as a determinant of cancer cell survival: a possible mechanism for de novo drug resistance.
description
2000 nî lūn-bûn
@nan
2000 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
The tumor microenvironment as ...... m for de novo drug resistance.
@ast
The tumor microenvironment as ...... m for de novo drug resistance.
@en
The tumor microenvironment as ...... m for de novo drug resistance.
@nl
type
label
The tumor microenvironment as ...... m for de novo drug resistance.
@ast
The tumor microenvironment as ...... m for de novo drug resistance.
@en
The tumor microenvironment as ...... m for de novo drug resistance.
@nl
prefLabel
The tumor microenvironment as ...... m for de novo drug resistance.
@ast
The tumor microenvironment as ...... m for de novo drug resistance.
@en
The tumor microenvironment as ...... m for de novo drug resistance.
@nl
P2093
P1476
The tumor microenvironment as ...... m for de novo drug resistance.
@en
P2093
P304
P356
10.1097/00001622-200011000-00008
P577
2000-11-01T00:00:00Z